+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Insulin Delivery Devices Market - Forecasts from 2019 to 2024

  • ID: 4895760
  • Report
  • November 2019
  • Region: Global
  • 118 pages
  • Knowledge Sourcing Intelligence LLP

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Biocon Limited
  • ELI Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • Medtronic
  • Novo Nordisk
  • MORE
The insulin delivery devices market is estimated to reach US$16.8744 billion by 2024 from US$11.231 billion in 2018 growing at a CAGR of 7.02%. Insulin Delivery Devices are used to administer insulin to the diabetic patients. There are many different types of insulin delivery devices available including syringes, delivery devices, jet injectors, oral insulin and pumps etc. giving patients number of options to decide as per their ease and convenience. Alternate forms of insulin delivery are being developed to overcome problems with current subcutaneous insulin injection therapy like poor compliance due to pain, variable absorption lack of feedback control. Insulin Delivery Devices market will show robust growth during the forecast period owing to the rising prevalence of the diabetes because of sedentary life style and rising number of geriatric population across the globe. Continuous technological innovations and advancements in insulin delivery devices for increasing patient compliance will also boost the adoption of the Insulin Delivery Devices during the given forecast period. Poor reimbursement structure and insurance coverage in developing countries might restrain the growth of the Insulin Delivery Devices market during the given time frame.

The Insulin Delivery Devices Market - Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by types, application, end users and geography.
The insulin delivery devices market has been segmented based on by types, application, and geography. By types, the market is segmented as insulin pens, syringes, insulin pumps, inhalers and others. By application, market is segmented as type I diabetes, type II diabetes and gestational diabetes. On the basis of end users market is segmented as hospitals and clinics, ambulatory care settings and home care settings.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major industry players profiled as part of the report are Novo Nordisk, Becton, Dickinson and Company, Medtronic, Sanofi, and ELI Lilly and Company among others.

Segmentation

By Types
  • Insulin Delivery devices
  • Syringes
  • Insulin Pumps
  • Inhalers
  • Others
By Application
  • Type I Diabetes
  • Type II Diabetes
  • Gestational Diabetes
By End Users
  • Hospitals and Clinics
  • Ambulatory Care Settings
  • Home Care Settings
By Geography

North America
  • U.S.
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
Europe
  • UK
  • Germany
  • France
  • Spain
  • Others
Middle East and Africa
  • UAE
  • Israel
  • Others
  • Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
  • Others
The report will be delivered in 3 working days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biocon Limited
  • ELI Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • Medtronic
  • Novo Nordisk
  • MORE
1. Introduction
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, And Forecast Years Timeline

2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. INSULIN DELIVERY DEVICES MARKET BY TYPES
5.1. Insulin Delivery devices
5.2. Syringes
5.3. Insulin Pumps
5.4. Inhalers
5.5. Others

6. INSULIN DELIVERY DEVICES MARKET BY APPLICATION
6.1. Type I Diabetes
6.2. Type II Diabetes
6.3. Gestational Diabetes

7. INSULIN DELIVERY DEVICES MARKET BY END USERS
7.1. Hospitals and Clinics
7.2. Ambulatory Care Settings
7.3. Home Care Settings

8. NORTH AMERICA INSULIN DELIVERY DEVICES MARKET FORECAST AND TRENDS
8.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
8.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
8.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
8.4. By Country
8.4.1. United States
8.4.1.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
8.4.1.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
8.4.1.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
8.4.2. Canada
8.4.2.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
8.4.2.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
8.4.2.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
8.4.3. Mexico
8.4.3.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
8.4.3.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
8.4.3.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)

9. SOUTH AMERICA INSULIN DELIVERY DEVICES MARKET
9.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
9.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
9.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
9.4. By Country
9.4.1. Brazil
9.4.1.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
9.4.1.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
9.4.1.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
9.4.2. Argentina
9.4.2.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
9.4.2.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
9.4.2.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
9.4.3. Others (US$ Million)(Units)

10. EUROPE INSULIN DELIVERY DEVICES MARKET
10.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
10.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
10.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
10.4. By Country
10.4.1. Germany
10.4.1.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
10.4.1.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
10.4.1.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
10.4.2. France
10.4.2.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
10.4.2.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
10.4.2.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
10.4.3. United Kingdom
10.4.3.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
10.4.3.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
10.4.3.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
10.4.4. Spain
10.4.4.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
10.4.4.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
10.4.4.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
10.4.5. Others (US$ Million)(Units)

11. MIDDLE EAST AND AFRICA INSULIN DELIVERY DEVICES MARKET
11.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
11.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
11.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
11.4. By Country
11.4.1. UAE
11.4.1.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
11.4.1.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
11.4.1.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
11.4.2. Israel
11.4.2.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
11.4.2.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
11.4.2.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
11.4.3. Others (US$ Million)(Units)

12. ASIA PACIFIC INSULIN DELIVERY DEVICES MARKET
12.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
12.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
12.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
12.4. By Country
12.4.1. China
12.4.1.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
12.4.1.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
12.4.1.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
12.4.2. Japan
12.4.2.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
12.4.2.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
12.4.2.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
12.4.3. India
12.4.3.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
12.4.3.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
12.4.3.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
12.4.4. South Korea
12.4.4.1. Market Size and Forecast, By Types, 2018 to 2024 (US$ Million)
12.4.4.2. Market Size and Forecast, By Application, 2018 to 2024 (US$ Million)
12.4.4.3. Market Size and Forecast, By End Users, 2018 to 2024 (US$ Million)
12.4.5. Others (US$ Million)(Units)

13. COMPETITIVE INTELLIGENCE
13.1. Competitive Benchmarking and Analysis
13.2. Strategies of Key Players
13.3. Recent Investments and Deals

14. COMPANY PROFILES
14.1. Novo Nordisk
14.2. Becton, Dickinson and Company
14.3. Medtronic
14.4. Sanofi
14.5. ELI Lilly and Company
14.6. Ypsomed AG
14.7. Biocon Limited
14.8. Insulet Corporation
14.9. Tandem Diabetes Care, Inc.
14.10. F. Hoffmann-La Roche Ltd
Note: Product cover images may vary from those shown
  • Novo Nordisk
  • Becton, Dickinson and Company
  • Medtronic
  • Sanofi
  • ELI Lilly and Company
  • Ypsomed AG
  • Biocon Limited
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • F. Hoffmann-La Roche Ltd
Note: Product cover images may vary from those shown
Adroll
adroll